Wilzin 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
1 issued on 
Decision 
Issued2 / 
amended 
on 
Information 
affected3 
SmPC, Annex 
II, Labelling 
and PL 
IG/1085/G 
This was an application for a group of variations. 
16/05/2019 
A.1 - Administrative change - Change in the name 
and/or address of the MAH 
A.5.a - Administrative change - Change in the name 
and/or address of a manufacturer/importer 
responsible for batch release 
A.5.a - Administrative change - Change in the name 
and/or address of a manufacturer/importer 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are 
issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD 
is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
  
 
 
 
 
 
 
                                                
responsible for batch release 
A.5.b - Administrative change - Change in the name 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
N/0030 
Minor change in labelling or package leaflet not 
11/03/2019 
PL 
connected with the SPC (Art. 61.3 Notification) 
IA/0029/G 
This was an application for a group of variations. 
14/01/2019 
n/a 
A.7 - Administrative change - Deletion of 
manufacturing sites 
A.7 - Administrative change - Deletion of 
manufacturing sites 
A.7 - Administrative change - Deletion of 
manufacturing sites 
A.7 - Administrative change - Deletion of 
manufacturing sites 
B.III.1.b.2 - Submission of a new/updated or deletion 
of Ph. Eur. TSE Certificate of Suitability - New 
certificate for a starting 
material/reagent/intermediate/or excipient from a 
new or an already approved manufacturer 
B.III.1.b.2 - Submission of a new/updated or deletion 
of Ph. Eur. TSE Certificate of Suitability - New 
certificate for a starting 
material/reagent/intermediate/or excipient from a 
new or an already approved manufacturer 
B.III.1.b.2 - Submission of a new/updated or deletion 
of Ph. Eur. TSE Certificate of Suitability - New 
certificate for a starting 
Wilzin  
EMA/336148/2019 
Page 2/9 
  
  
 
 
 
 
 
 
 
material/reagent/intermediate/or excipient from a 
new or an already approved manufacturer 
B.III.1.b.2 - Submission of a new/updated or deletion 
of Ph. Eur. TSE Certificate of Suitability - New 
certificate for a starting 
material/reagent/intermediate/or excipient from a 
new or an already approved manufacturer 
B.III.1.b.4 - Submission of a new/updated or deletion 
of Ph. Eur. TSE Certificate of Suitability - Deletion of 
certificates (in case multiple certificates exist per 
material) 
N/0028 
Minor change in labelling or package leaflet not 
24/07/2018 
connected with the SPC (Art. 61.3 Notification) 
Labelling and 
PL 
PSUSA/3145/
Periodic Safety Update EU Single assessment - zinc 
09/06/2017 
n/a 
PRAC Recommendation - maintenance 
201610 
acetate dihydrate 
IG/0773/G 
This was an application for a group of variations. 
14/02/2017 
19/02/2018 
Annex II and PL 
B.II.b.1.a - Replacement or addition of a 
manufacturing site for the FP - Secondary packaging 
site 
B.II.b.2.c.1 - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - Not 
including batch control/testing 
IA/0025 
B.II.d.2.a - Change in test procedure for the finished 
08/12/2016 
n/a 
product - Minor changes to an approved test 
procedure 
Wilzin  
EMA/336148/2019 
Page 3/9 
  
  
 
 
 
 
 
 
 
 
 
 
 
IA/0024 
B.II.d.2.a - Change in test procedure for the finished 
25/11/2016 
n/a 
product - Minor changes to an approved test 
procedure 
IA/0023 
A.5.b - Administrative change - Change in the name 
24/06/2016 
n/a 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
IG/0686 
B.II.b.1.a - Replacement or addition of a 
12/05/2016 
n/a 
manufacturing site for the FP - Secondary packaging 
site 
IA/0021/G 
This was an application for a group of variations. 
23/07/2015 
n/a 
B.III.1.b.2 - Submission of a new/updated or deletion 
of Ph. Eur. TSE Certificate of Suitability - New 
certificate for a starting 
material/reagent/intermediate/or excipient from a 
new or an already approved manufacturer 
B.III.1.b.3 - Submission of a new/updated or deletion 
of Ph. Eur. TSE Certificate of Suitability - Updated 
certificate from an already approved manufacturer 
B.III.1.b.4 - Submission of a new/updated or deletion 
of Ph. Eur. TSE Certificate of Suitability - Deletion of 
certificates (in case multiple certificates exist per 
material) 
IA/0020 
B.II.b.4.b - Change in the batch size (including batch 
12/06/2015 
n/a 
size ranges) of the finished product - Downscaling 
down to 10-fold 
Wilzin  
EMA/336148/2019 
Page 4/9 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IB/0019 
To extend the shelf life of the finished product from 24 
18/05/2015 
17/05/2016 
SmPC and PL 
to 36 months. The MAH has also taken the opportunity 
to update the local representatives in the PIL. 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf life 
of the finished product - As packaged for sale 
(supported by real time data) 
IAIN/0018/G 
This was an application for a group of variations. 
15/04/2015 
n/a 
B.I.a.1.a - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - The 
proposed manufacturer is part of the same 
pharmaceutical group as the currently approved 
manufacturer 
B.I.a.1.f - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - 
Changes to quality control testing arrangements for 
the AS -replacement or addition of a site where batch 
control/testing takes place 
IB/0017 
B.II.c.2.d - Change in test procedure for an excipient - 
10/03/2015 
n/a 
Other changes to a test procedure (including 
replacement or addition) 
IG/0535 
C.I.8.a - Introduction of or changes to a summary of 
06/03/2015 
n/a 
Pharmacovigilance system - Changes in QPPV 
(including contact details) and/or changes in the PSMF 
location 
Wilzin  
EMA/336148/2019 
Page 5/9 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IA/0015/G 
This was an application for a group of variations. 
17/12/2014 
n/a 
B.II.c.2.a - Change in test procedure for an excipient - 
Minor changes to an approved test procedure 
B.II.c.2.a - Change in test procedure for an excipient - 
Minor changes to an approved test procedure 
B.II.c.3.a.1 - Change in source of an excipient or 
reagent with TSE risk - From TSE risk material to 
vegetable or synthetic origin - For excipients or 
reagents NOT used in the manufacture of a 
biol/immunol AS or in a biol/immunol medicinal 
product 
B.III.1.b.2 - Submission of a new/updated or deletion 
of Ph. Eur. TSE Certificate of Suitability - New 
certificate for a starting 
material/reagent/intermediate/or excipient from a 
new or an already approved manufacturer 
B.III.1.b.3 - Submission of a new/updated or deletion 
of Ph. Eur. TSE Certificate of Suitability - Updated 
certificate from an already approved manufacturer 
B.III.1.b.4 - Submission of a new/updated or deletion 
of Ph. Eur. TSE Certificate of Suitability - Deletion of 
certificates (in case multiple certificates exist per 
material) 
IG/0393 
C.I.8.a - Introduction of or changes to a summary of 
20/12/2013 
n/a 
Pharmacovigilance system - Changes in QPPV 
(including contact details) and/or changes in the PSMF 
location 
IG/0392 
B.II.b.2.c.1 - Change to importer, batch release 
19/12/2013 
29/01/2014 
Annex II and PL 
arrangements and quality control testing of the FP - 
Wilzin  
EMA/336148/2019 
Page 6/9 
  
  
 
 
 
 
 
 
 
 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - Not 
including batch control/testing 
IB/0011/G 
This was an application for a group of variations. 
13/12/2013 
n/a 
B.II.b.1.b - Replacement or addition of a 
manufacturing site for the FP - Primary packaging site 
B.II.b.1.e - Replacement or addition of a 
manufacturing site for the FP - Site where any 
manufacturing operation(s) take place, except 
batch-release, batch control, primary and secondary 
packaging, for non-sterile medicinal products 
B.II.b.2.a - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
IA/0012 
A.4 - Administrative change - Change in the name 
14/11/2013 
n/a 
and/or address of a manufacturer or an ASMF holder 
or supplier of the AS, starting material, reagent or 
intermediate used in the manufacture of the AS or 
manufacturer of a novel excipient 
IB/0010 
C.I.3.a - Implementation of change(s) requested 
17/01/2013 
29/01/2014 
SmPC and PL 
following the assessment of an USR, class labelling, a 
PSUR, RMP, FUM/SO, data submitted under A 45/46, 
or amendments to reflect a Core SPC - Changes with 
NO new additional data are submitted by the MAH 
N/0009 
Minor change in labelling or package leaflet not 
12/09/2012 
29/01/2014 
PL 
connected with the SPC (Art. 61.3 Notification) 
Wilzin  
EMA/336148/2019 
Page 7/9 
  
  
 
 
 
 
 
 
 
 
 
 
 
N/0008 
Minor change in labelling or package leaflet not 
23/01/2012 
29/01/2014 
PL 
connected with the SPC (Art. 61.3 Notification) 
IB/0007 
B.II.d.1.g - Change in the specification parameters 
28/07/2010 
n/a 
and/or limits of the finished product - Addition or 
replacement (excluding biological or immunological 
product) of a specification parameter as a result of a 
safety or quality issue 
IB/0006 
IB_12_a_Change in spec. of active subst./agent used 
20/01/2010 
n/a 
in manuf. of active subst. - tightening 
IB_12_b_01_Change in spec. of active subst./agent in 
manuf. of active subst. - test parameter AS 
IB_25_a_01_Change to comply with Ph. - compliance 
with EU Ph. - active substance 
R/0005 
Renewal of the marketing authorisation. 
23/07/2009 
19/10/2009 
SmPC, Annex 
Based on the review of the available information the CHMP is 
II, Labelling 
of the opinion that the quality, the safety and the efficacy of 
and PL 
this medicinal product continues to be adequately and 
sufficiently demonstrated and therefore considers that the 
benefit/risk profile continues to be favourable. The CHMP 
was also of the opinion that the renewal can be granted with 
unlimited validity. 
IA/0004 
IA_01_Change in the name and/or address of the 
06/09/2007 
n/a 
SmPC, Annex 
marketing authorisation holder 
IA_05_Change in the name and/or address of a 
manufacturer of the finished product 
II, Labelling 
and PL 
IA/0002 
IA_36_ b_Change in shape or dimensions of the 
06/06/2007 
n/a 
container/closure - other pharm. forms 
Wilzin  
EMA/336148/2019 
Page 8/9 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IA/0001 
IA_07_a_Replacement/add. of manufacturing site: 
12/05/2006 
n/a 
Secondary packaging site 
Wilzin  
EMA/336148/2019 
Page 9/9 
  
  
 
 
 
 
  
